The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy
نویسندگان
چکیده
منابع مشابه
The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy
BACKGROUND Depression and Health Related Quality of Life have been associated with prognosis in lung cancer. As the Distress Thermometer measures emotional problems and may share similarities with aspects of Health Related Quality of Life, we aimed to retrospectively assess the prognostic value of the Distress Thermometer in lung cancer patients treated with chemotherapy. METHODS Patients wit...
متن کاملImmunoscore® as a predictor of response to chemotherapy in stage II and stage III colon cancer
Background No biomarker has been validated so far to predict the need for adjuvant chemotherapy in Stage II colon cancer (CC), and current guidelines, e.g. NCCN, only rely on the identification of high-risk features such as MSI, pathological tumor characteristics or expected chemotherapy efficacy/safety ratio in each individual patient. In contrast, adjuvant chemotherapy is recommended for all ...
متن کاملBMI is a Predictor of Survival in Breast Cancer Patients Treated with Adjuvant Radiotherapy and Chemotherapy
Breast cancer is the most common malignant disease among women and second leading cause of cancer-related deaths (Siegel et al., 2012; Wu et al., 2014). American Cancer Society (ACS) estimates that 29% of all newly diagnosed malignant disease will be breast cancer and it will be cause in 16% of the deaths (Parekh et al., 2012; Siegel et al., 2012; Taghavi et al., 2012). Increased number of surv...
متن کاملTreatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Despite the good responses of patients (pts) with stage III breast cancer to neoadjuvant chemotherapy (NAC), most eventually relapse and have a poor prognosis. We investigated the prognostic indicators in pts with stage III breast cancer treated with NAC, using epirubicin and/or docetaxel. A total of 22 women with stage III breast cancer underwent NAC between January 2005 and May 2011. The regi...
متن کاملBetter cancer specific survival in young small cell lung cancer patients especially with AJCC stage III
It has been reported that younger patients with non-small cell lung cancer (NSCLC) tend to have a better prognosis. Yet, few studies have focused on the clinicopathological characteristics and prognosis of young small cell lung cancer (SCLC), especially for patients with age < 50. In our study, we used Surveillance, Epidemiology, and End Results (SEER) population-based data and identified 16503...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2016
ISSN: 1949-2553
DOI: 10.18632/oncotarget.14151